↓ Skip to main content

Therapeutic Use of Dendritic Cells to Promote the Extranodal Priming of Anti-Tumor Immunity

Overview of attention for article published in Frontiers in immunology, January 2013
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
31 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Therapeutic Use of Dendritic Cells to Promote the Extranodal Priming of Anti-Tumor Immunity
Published in
Frontiers in immunology, January 2013
DOI 10.3389/fimmu.2013.00388
Pubmed ID
Authors

Lu Chen, Kellsye L. Fabian, Jennifer L. Taylor, Walter J. Storkus

Abstract

Ectopic lymphoid tissue, also known as tertiary lymphoid organs (TLO) develop adaptively within sites of chronic tissue inflammation, thereby allowing the host to efficiently crossprime specific immune effector cells within sites of disease. Recent evidence suggests that the presence of TLO in the tumor microenvironment (TME) predicts better overall survival. We will discuss the relevance of extranodal T cell priming within the TME as a means to effectively promote anti-tumor immunity and the strategic use of dendritic cell (DC)-based therapies to reinforce this clinically preferred process in the cancer-bearing host.

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 3%
Unknown 30 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 26%
Student > Ph. D. Student 6 19%
Student > Bachelor 5 16%
Student > Master 4 13%
Other 1 3%
Other 1 3%
Unknown 6 19%
Readers by discipline Count As %
Agricultural and Biological Sciences 8 26%
Immunology and Microbiology 7 23%
Biochemistry, Genetics and Molecular Biology 4 13%
Medicine and Dentistry 3 10%
Psychology 1 3%
Other 1 3%
Unknown 7 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 November 2013.
All research outputs
#23,475,307
of 26,150,873 outputs
Outputs from Frontiers in immunology
#28,322
of 32,975 outputs
Outputs of similar age
#262,924
of 293,399 outputs
Outputs of similar age from Frontiers in immunology
#337
of 503 outputs
Altmetric has tracked 26,150,873 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 32,975 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 293,399 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 503 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.